Published in BMC Res Notes on June 15, 2013
Inadequate Utilization of Diagnostic Colonoscopy Following Abnormal FIT Results in an Integrated Safety-Net System. Am J Gastroenterol (2016) 0.76
Physician response to surveys. A review of the literature. Am J Prev Med (2001) 7.69
Open-access endoscopy service for general practitioners. Br Med J (1979) 6.07
Variation of quality of colonoscopy in Italy over five years: a nation-wide observational study. Dig Liver Dis (2012) 2.64
Appropriateness and diagnostic yield of upper gastrointestinal endoscopy in an open-access endoscopy unit. Endoscopy (1996) 2.55
Practice variations and health care reform: connecting the dots. Health Aff (Millwood) (2004) 2.40
Variation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States. J Pediatr Gastroenterol Nutr (2011) 1.96
ASGE guideline: The role of endoscopy in the diagnosis and the management of cystic lesions and inflammatory fluid collections of the pancreas. Gastrointest Endosc (2005) 1.74
Capsule endoscopy in patients with Crohn's disease: diagnostic yield and safety. Gastrointest Endosc (2009) 1.73
Unexplained iron deficiency anaemia: Is it worthwhile to perform capsule endoscopy? Dig Liver Dis (2010) 1.68
Assessment of the quality of colonoscopy reports: results from a multicenter consortium. Gastrointest Endosc (2009) 1.64
The ASGE guidelines for the appropriate use of upper gastrointestinal endoscopy in an open access system. Gastrointest Endosc (1995) 1.56
Are patients who undergo open-access endoscopy more anxious about their procedures than patients referred from the GI clinic? Am J Gastroenterol (1996) 1.53
Quality indicators for gastrointestinal endoscopic procedures: an introduction. Am J Gastroenterol (2006) 1.30
Strategies to address increased demand for colonoscopy: Guidelines in an open endoscopy practice. Clin Gastroenterol Hepatol (2004) 1.28
Accuracy of linear endoscopic ultrasonography in the evaluation of patients with suspected common bile duct stones. Endoscopy (2002) 1.23
Differences in the management of Crohn's disease among experts and community providers, based on a national survey of sample case vignettes. Aliment Pharmacol Ther (2007) 1.23
Diagnosis of choledocholithiasis: EUS or magnetic resonance cholangiography? A prospective controlled study. Gastrointest Endosc (1999) 1.09
Do physicians follow evidence-based guidelines in the diagnostic work-up of IBS? Nat Clin Pract Gastroenterol Hepatol (2007) 1.05
Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther (2009) 0.98
EUS for suspected choledocholithiasis: do benefits outweigh costs? A prospective, controlled study. Gastrointest Endosc (2003) 0.95
Diagnostic yield of capsule endoscopy in a tertiary hospital in patients with obscure gastrointestinal bleeding. J Gastrointestin Liver Dis (2010) 0.95
Evaluating the process of care in nonvariceal upper gastrointestinal haemorrhage: a survey of expert vs. non-expert gastroenterologists. Aliment Pharmacol Ther (2008) 0.94
Do gastroenterologists adhere to diagnostic and treatment guidelines for celiac disease? J Clin Gastroenterol (2012) 0.88
Temporal trends over ten years in formal inpatient gastroenterology consultations at an inner city hospital. J Clin Gastroenterol (2003) 0.86
A prospective analysis of inpatient consultations to a gastroenterology service. Ir Med J (2003) 0.85
Consultation patterns and clinical correlates of consultation in a tertiary care setting. BMC Res Notes (2008) 0.81
Variation in care for children with esophageal varices: a study of physicians', patients', and families' approaches and attitudes. J Pediatr Gastroenterol Nutr (2011) 0.79
A wide variation in diagnostic and therapeutic strategies in chronic pancreatitis: a Dutch national survey. JOP (2012) 0.78
Characteristics of best gastroenterology practices. Am J Gastroenterol (1999) 0.77
Audit of patients' experiences after endoscopy of the upper alimentary tract. Br J Clin Pract (1994) 0.77
American College of Gastroenterology guidelines for colorectal cancer screening 2009 [corrected]. Am J Gastroenterol (2009) 12.16
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. Gastroenterology (2011) 5.93
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol (2008) 2.39
Magnitude and economic impact of inappropriate use of stress ulcer prophylaxis in non-ICU hospitalized patients. Am J Gastroenterol (2006) 2.38
Esophageal adenocarcinoma incidence in individuals with gastroesophageal reflux: synthesis and estimates from population studies. Am J Gastroenterol (2010) 2.37
AGA Institute review of endoscopic sedation. Gastroenterology (2007) 2.35
Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control. Blood (2008) 2.30
Prediction of Barrett's esophagus among men. Am J Gastroenterol (2013) 2.22
National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med (2009) 2.19
eReferral--a new model for integrated care. N Engl J Med (2013) 2.14
Nonpolypoid neoplastic lesions of the colorectal mucosa. Gastrointest Endosc (2008) 2.09
Exploring utilities and outcomes with infliximab therapy. Clin Gastroenterol Hepatol (2006) 2.04
Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans. Gastrointest Endosc (2008) 1.96
Not perfect, but better: primary care providers' experiences with electronic referrals in a safety net health system. J Gen Intern Med (2009) 1.86
RhoA-kinase and myosin II are required for the maintenance of growth cone polarity and guidance by nerve growth factor. J Neurobiol (2006) 1.79
Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. Am J Gastroenterol (2009) 1.74
Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004. Am J Gastroenterol (2008) 1.68
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl (2011) 1.67
Evaluating electronic referrals for specialty care at a public hospital. J Gen Intern Med (2010) 1.67
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
Challenges and possible solutions to colorectal cancer screening for the underserved. J Natl Cancer Inst (2014) 1.61
A cost-utility analysis of secondary prophylaxis for variceal hemorrhage. Am J Gastroenterol (2004) 1.51
National Institutes of Health consensus development conference statement: management of hepatitis B. Hepatology (2009) 1.48
Practice profile. A safety-net system gains efficiencies through 'eReferrals' to specialists. Health Aff (Millwood) (2010) 1.42
Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol (2008) 1.38
Formal patient education improves patient knowledge of hepatitis C in vulnerable populations. Dig Dis Sci (2010) 1.35
Magnitude and economic effect of overuse of antisecretory therapy in the ambulatory care setting. Am J Manag Care (2010) 1.35
American Gastroenterological Association Institute technical review on the use of thiopurines, methotrexate, and anti-TNF-α biologic drugs for the induction and maintenance of remission in inflammatory Crohn's disease. Gastroenterology (2013) 1.32
HIV controllers with HLA-DRB1*13 and HLA-DQB1*06 alleles have strong, polyfunctional mucosal CD4+ T-cell responses. J Virol (2010) 1.29
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology (2013) 1.27
Cost utility of screening for Barrett's esophagus with esophageal capsule endoscopy versus conventional upper endoscopy. Clin Gastroenterol Hepatol (2007) 1.25
Healthcare reform with a safety net: lessons from San Francisco. Am J Manag Care (2009) 1.24
Actin turnover is required to prevent axon retraction driven by endogenous actomyosin contractility. J Cell Biol (2002) 1.23
Women patients' preference for women physicians is a barrier to colon cancer screening. Gastrointest Endosc (2005) 1.20
Adverse events in older patients undergoing colonoscopy: a systematic review and meta-analysis. Gastrointest Endosc (2011) 1.18
Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers. J Virol (2010) 1.14
Improving the primary care-specialty care interface: getting from here to there. Arch Intern Med (2009) 1.10
Associations of diabetes mellitus, insulin, leptin, and ghrelin with gastroesophageal reflux and Barrett's esophagus. Gastroenterology (2013) 1.09
Cost-effective treatment of patients with symptomatic cholelithiasis and possible common bile duct stones. J Am Coll Surg (2011) 1.07
Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med (2003) 1.07
Pragmatic classification of superficial neoplastic colorectal lesions. Gastrointest Endosc (2009) 1.02
Primary-care physicians' perceptions and practices on the management of GERD: results of a national survey. Am J Gastroenterol (2005) 1.01
Gut epithelial barrier and systemic inflammation during chronic HIV infection. AIDS (2015) 0.99
Why you should care about screening flexible sigmoidoscopy. N Engl J Med (2012) 0.99
Protective role of gluteofemoral obesity in erosive oesophagitis and Barrett's oesophagus. Gut (2013) 0.98
Hospitalizations are increasing among minority patients with Crohn's disease and ulcerative colitis. Inflamm Bowel Dis (2010) 0.96
Vasopressin-mediated mitogenic signaling in intestinal epithelial cells. Am J Physiol Cell Physiol (2002) 0.95
p38 MAP kinase mediates platelet-derived growth factor-stimulated migration of hepatic myofibroblasts. J Cell Physiol (2002) 0.95
Management of obscure occult gastrointestinal bleeding: a cost-minimization analysis. Clin Gastroenterol Hepatol (2008) 0.95
On-demand therapy for gastroesophageal reflux disease. Am J Gastroenterol (2007) 0.94
Hepatitis B surface antigenemia in chronic hemodialysis patients: effect of hepatitis B immunization. Am J Gastroenterol (2002) 0.93
Health disparities in liver disease: Time to take notice and take action. Hepatology (2009) 0.93
[Ca2+]i-independent contractile force generation by rat hepatic stellate cells in response to endothelin-1. Am J Physiol Gastrointest Liver Physiol (2005) 0.93
Quality indicators for EGD. Gastrointest Endosc (2014) 0.92
Concurrent Obesity, Diabetes, and Steatosis Increase Risk of Advanced Fibrosis Among HCV Patients: A Systematic Review. Dig Dis Sci (2015) 0.91
Stellate cell contraction: role, regulation, and potential therapeutic target. Clin Liver Dis (2008) 0.91
Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis. Am J Physiol Gastrointest Liver Physiol (2007) 0.91
Improving primary care-specialty care communication: lessons from San Francisco's safety net: comment on "Referral and consultation communication between primary care and specialist physicians". Arch Intern Med (2011) 0.91
Hepatic stellate cell protrusions couple platelet-derived growth factor-BB to chemotaxis. Hepatology (2007) 0.91
Race and inflammatory bowel disease in an urban healthcare system. Dig Dis Sci (2010) 0.90
Platelet-derived growth factor-BB and lysophosphatidic acid distinctly regulate hepatic myofibroblast migration through focal adhesion kinase. Exp Cell Res (2002) 0.89
In search of quality colonoscopy. Gastroenterology (2008) 0.89
Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies. J Clin Gastroenterol (2016) 0.87
Quality indicators for EGD. Am J Gastroenterol (2014) 0.87
Cirrhosis--can we reverse hepatic fibrosis? Eur J Surg Suppl (2002) 0.85
Preconsultation exchange for ambulatory hepatology consultations. Am J Med (2013) 0.85
Anesthesia for colonoscopy: too much of a good thing? JAMA Intern Med (2013) 0.83
New model for end stage liver disease improves prognostic capability after transjugular intrahepatic portosystemic shunt. Clin Gastroenterol Hepatol (2009) 0.83
Non-English speakers attend gastroenterology clinic appointments at higher rates than English speakers in a vulnerable patient population. J Clin Gastroenterol (2009) 0.83
Prevention of complicated ulcer disease among chronic users of nonsteroidal anti-inflammatory drugs: the use of a nomogram in cost-effectiveness analysis. Arch Intern Med (2002) 0.83
Risk stratification in upper gastrointestinal bleeding. J Clin Gastroenterol (2007) 0.82
Comparison of the cost and effectiveness of two strategies for maintaining hepatitis B immunity in hemodialysis patients. Vaccine (2002) 0.82
FIT testing: an overview. Curr Gastroenterol Rep (2013) 0.81
Understanding liver health using the National Center for Health Statistics. Dig Dis Sci (2009) 0.81
Rho and p38 MAP kinase signaling pathways mediate LPA-stimulated hepatic myofibroblast migration. J Biomed Sci (2003) 0.81
C-type natriuretic peptide induces human colonic myofibroblast relaxation. Am J Physiol Gastrointest Liver Physiol (2003) 0.80
From the bedside to the community: comparative effectiveness, health services, and implementation research. Hepatology (2011) 0.80
Time to burn? Endoscopic ablation for Barrett's esophagus. Gastroenterology (2011) 0.79
Intestinal myofibroblasts produce nitric oxide in response to combinatorial cytokine stimulation. J Cell Physiol (2013) 0.79
Defining a clinically significant adverse impact of diagnosing Barrett's esophagus. J Clin Gastroenterol (2006) 0.78
Empiric beta-blockers for the prophylaxis of variceal hemorrhage: cost effective or clinically applicable? Hepatology (2003) 0.78
A glossary of economic terms. Eur J Gastroenterol Hepatol (2004) 0.78
Esophageal varices on computed tomography and subsequent variceal hemorrhage. Abdom Imaging (2014) 0.77
Diverticular disease: evolving concepts in classification, presentation, and management. Curr Opin Gastroenterol (2015) 0.77
Gastric cancer in asian american populations: a neglected health disparity. Asian Pac J Cancer Prev (2014) 0.76
13-year mortality trends among hospitalized patients with inflammatory bowel disease. BMC Gastroenterol (2012) 0.75
In search of an ideal biomarker for nonalcoholic fatty liver disease. Am J Gastroenterol (2008) 0.75
Inducible NOS mediates CNP-induced relaxation of intestinal myofibroblasts. Am J Physiol Gastrointest Liver Physiol (2013) 0.75
Inoperable pancreatic cancer patients who have prolonged survival exhibit an increased risk of cholangitis. JOP (2011) 0.75
Proton pump inhibitors and hip fracture: cause for alarm? Gastroenterology (2007) 0.75
Is 325 mg of prevention worth a pound of cure? Gastroenterology (2012) 0.75
Will virtual colonoscopy replace optical colonoscopy for colorectal cancer screening? Gastroenterology (2007) 0.75
Patients prefer conventional to virtual colonoscopy. Gastroenterology (2007) 0.75
Dysphagia drives doctors to diagnose a disease: pitfalls in interpreting observational studies. Gastrointest Endosc (2005) 0.75
Potential for lead-time and length-time biases in outcomes in esophageal adenocarcinoma. Am J Gastroenterol (2009) 0.75
Medicaid and Uninsured Hepatocellular Carcinoma Patients Have More Advanced Tumor Stage and Are Less Likely to Receive Treatment. J Clin Gastroenterol (2017) 0.75